You are here

biotech

Too much success? A booming biotech pipeline will spur intense rivalries — analyst

Endpoints

Tue, 12/11/18 - 10:20 am

drug development

Nasdaq celebrates record biotech IPO success in 2018. But can the party on Wall Street rumba on?

Endpoints

Mon, 12/10/18 - 09:58 am

Could These Be the Next 2 Biotech Buyouts?

Motley Fool

Sun, 12/9/18 - 03:41 pm

Agios Pharmaceuticals

Clovis Oncology

Moderna, largest biotech to go public, fails to impress in market debut

Reuters

Sat, 12/8/18 - 12:29 pm

Moderna Therapeutics

BIO Applauds Inclusion of Pro-Growth Provisions in Tax and Oversight Legislation

Businesswire

Thu, 11/29/18 - 10:19 am

Can a biotech unicorn break into the record books with a $600M IPO? Stéphane Bancel has a fortune riding on the answer

Endpoints

Wed, 11/28/18 - 11:50 am

Stephane Bancel

The flip side of the hot IPO market? A chill could trigger a sudden cash crunch in biotech, followed by more deals

Endpoints

Wed, 11/28/18 - 09:57 am

In the latest reverse merger, Vienna's Arsanis serves as vehicle for X4 Pharma's Nasdaq listing

Endpoints

Tue, 11/27/18 - 11:29 pm

Biotech Showcase Conference Reveals Six Therapeutic Areas Receiving the Most Investment Attention in 2019

CP Wire

Tue, 11/27/18 - 12:02 pm

Alzheimer's disease

immuno-oncology

orphan diseases

Chinese foothold in U.S. biotech is growing, USTR report finds

BioCentury

Fri, 11/23/18 - 01:17 pm

California, Massachusetts go toe-to-toe for title of best biotech hub

Biopharma Dive

Wed, 11/14/18 - 04:36 pm

Preclinical biotech Synthorx wants a $100M IPO

Fierce Biotech

Wed, 11/14/18 - 11:51 am

immuno-oncology

A 29-Year-Old CEO Who's Shaking Up Diagnostics & Other Stories From The 2019 Healthcare 30 Under 30

Forbes

Tue, 11/13/18 - 09:53 am

Moderna aims to raise $500 million in biotech’s largest-ever public offering

Stat

Sat, 11/10/18 - 12:57 pm

Moderna Therapeutics

BIO Celebrates 300 Biotech IPOs since Enactment of the JOBS Act

Biotech Now

Sat, 11/10/18 - 12:04 pm

Biotech's big-bucks buybacks begin to burn

EP Vantage

Fri, 11/9/18 - 12:06 pm

Harvard gets $200M gift to accelerate early-stage R&D

Fierce Biotech

Fri, 11/9/18 - 11:36 am

AbbVie hatches plans for a major new R&D hub close to its partners in Bay Area's buzzy Oyster Point

Endpoints

Thu, 11/8/18 - 12:09 pm

Indicted for biotech insider trading, Rep. Chris Collins keeps his seat

Stat

Wed, 11/7/18 - 12:01 am

insider trading

Eli Lilly partner urges investors to look beyond biotech turmoil

Indianpolis Business Journal

Fri, 11/2/18 - 09:13 am

Innovent Biologics

Pages